D-0993-2019 Class II Terminated
FDA drug recall D-0993-2019 was initiated by Akorn, Inc. on Feb 22, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point. The recall status is terminated (terminated Aug 9, 2022). Affected quantity: 51,456 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 20, 2019
- Initiation Date
- Feb 22, 2019
- Termination Date
- Aug 9, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 51,456 bottles
Product description
Gentamicin Sulfate Ophthalmic Solution, USP, 0.3%, 5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045; NDC 17478-283-10.
Reason for recall
Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point.
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot 7B71A, Exp 01/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0993-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026